By Todd Neale, Senior Staff Writer, MedPage Today
Published: March 27, 2013
Reviewed by F. Perry Wilson, MD, MSCE; Instructor of Medicine, Perelman School of Medicine at the University of Pennsylvania and Dorothy Caputo, MA, BSN, RN, Nurse Planner
- Note that this systematic review demonstrated improved costs and outcomes among adherent patients in studies of primary or secondary prevention of coronary artery disease.
- Be aware that few studies contained an adequate control group to adjust for a “healthy adherer” effect.
Greater adherence to medications for primary and secondary prevention of coronary artery disease appears to improve outcomes and lower costs, a systematic review showed.
Although medication adherence was measured with various techniques, all primary and secondary prevention studies suggested that patients who were most adherent to their medication regimens had better outcomes compared with their less-adherent counterparts, according to Asaf Bitton, MD, MPH, of Brigham and Women’s Hospital in Boston, and colleagues.